Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esposito, G.
Right arrow Articles by Lise, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esposito, G.
Right arrow Articles by Lise, M.
Related Collections
Right arrow Chemotherapy
Right arrow Prognostic factors
Right arrow Surgery
Annals of Surgical Oncology 8:311-318 (2001)
© 2001 Society of Surgical Oncology


ORIGINAL ARTICLES

p27kip1 Expression Is Associated With Tumor Response to Preoperative Chemoradiotherapy in Rectal Cancer

Giovanni Esposito, MD, Salvatore Pucciarelli, MD, Rita Alaggio, MD, Luciano Giacomelli, PhD, Elisabetta Marchiori, MD, Gaetano Antonio Iaderosa, MD, Maria Luisa Friso, MD, Paola Toppan, MD, Luigi Chieco-Bianchi, MD and Mario Lise, MD

From the Sections of Oncology (GE, LC-B), II Clinical Surgery (SP, EM, PT, ML), and Pathology (RA, LG, GAI) of the Department of Oncology and Surgery of the University of Padova; and the Molecular Diagnostic Oncology Service (GE, LC-B), and Division of Radiology (MLF) of the City Hospital of Padova; Padova, Italy.

Correspondence: Address correspondence and reprint requests to: Giovanni Esposito, MD, Servizio Citodiagnostica Molecolare Oncologica, Via Gattamelata, 64, 35128 - Padova, Italy; Fax: 39-049-8072854; E-mail: cmaltese{at}ux1.unipd.it

Background: Our aim was to ascertain whether or not the response to preoperative chemoradiotherapy for rectal cancer is associated with p27kip1 and p53 protein expression.

Methods: Thirty-eight patients (27 male, 11 female) with a mean age of 59 years (age range 33–87) and stage II-III rectal cancer received preoperative chemoradiotherapy (45–50.4 Gy; 5-FU 350 mg/m2/day and leucovorin 10 mg/m2/day). Thirty-one underwent low anterior resection; seven underwent abdominoperineal excision. Endoscopic tumor biopsies, performed before adjuvant therapy, were evaluated for: histologic type, tumor differentiation, mitotic index, and p27kip1 and p53 protein expression which were immunohistochemically determined. p53 expression was graded as: a) absent or present in <=10% of tumor cells; b) present in 11–25%; c) present in 26–75%; and d) present in >75% of tumor cells. p27kip1 expression was assessed using both light microscopy (percent of stained cells x10 HPF) and cytometry with an image analysis workstation. Tumor response, ascertained with histology, was classified using a scale from 0 (no response) to 6 (complete pathologic response).

Results: The mitotic index for the endoscopic biopsies was low in 14 cases, moderate in 17 cases, and high in 7 cases. p53 protein expression was found in 21 (a), 3 (b), 3 (c), and 11 (d) cases. The mean percentage of cells expressing the p27kip1 protein was 34 (range 0–77.14%). A close correlation was found between cytometric and light microscopy findings for p27kip1 (r2 = 0.92, P = .0001). Tumor differentiation was good in 5 cases, poor in 2 cases, and moderate in the remaining 31 cases. While the response to adjuvant therapy was good/complete in 25 (65.78%) cases, it was absent/poor in 13 (34.21%) cases. Univariate analysis associated type of adjuvant therapy (chemoradiotherapy, P = .0428) and p27kip1 protein lower expression (P = .0148) with a poor response to adjuvant treatment. Stepwise linear regression found overexpression of p53 and p27kip1 and young age to be independent variables that were linked to a good response to adjuvant therapy.

Conclusions: Lack of p27kip1 and p53 protein expression in rectal cancer is associated with a poor response to preoperative adjuvant therapy.

Key Words: p27kip1 • p53 • Chemoradiotherapy • Rectal cancer




This article has been cited by other articles:


Home page
JCOHome page
B. M. Ghadimi, M. Grade, M. J. Difilippantonio, S. Varma, R. Simon, C. Montagna, L. Fuzesi, C. Langer, H. Becker, T. Liersch, et al.
Effectiveness of Gene Expression Profiling for Response Prediction of Rectal Adenocarcinomas to Preoperative Chemoradiotherapy
J. Clin. Oncol., March 20, 2005; 23(9): 1826 - 1838.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
H. G. Moore, J. Shia, D. S. Klimstra, L. Ruo, M. Mazumdar, G. K. Schwartz, B. D. Minsky, L. Saltz, and J. G. Guillem
Expression of p27 in Residual Rectal Cancer after Preoperative Chemoradiation Predicts Long-term Outcome
Ann. Surg. Oncol., November 1, 2004; 11(11): 955 - 961.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society of Surgical Oncology.